Jubilant Life Sciences Ltd has signed a long term supply agreement in proprietary products business with a leading international life sciences company. The total contract is valued at over $80 million, to be supplied in 3 years from the April –June quarter 2012. This contract has a minimum volume commitment and has an opportunity to go over $100 million. The company did not reveal the name of the partnering firm.
“This product has a huge demand in the market which is vindicated by the release of advance payment by the customer on the signing of the contract. The product under this contract is based on an in-house developed technology, integrated with captively produced raw material resulting in competitive advantage both in terms of cost of production and capital investment,” said a company statement.
The Company continues to see strong traction in the proprietary products business and expects to sign a few more contracts during the year which will further drive the momentum in revenues and profitability.